<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02157688</url>
  </required_header>
  <id_info>
    <org_study_id>SAFE Folliculitis Decalvans</org_study_id>
    <nct_id>NCT02157688</nct_id>
  </id_info>
  <brief_title>Impact of Staphylococcus Aureus on Folliculitis Decalvans</brief_title>
  <acronym>SAFE</acronym>
  <official_title>Role of Staphylococcus Aureus on Folliculitis Decalvans. A Comparative Bacteriological Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The folliculitis decalvans (FD) is an orphan disease , common in consultation specialized on
      scalp. This disease is currently not curable, responsible for significant for patients. The
      pathophysiology is poorly understood, Staphylococcus aureus (SA) appears to play a role,
      never previously studied, and the study will attempt to clarify it.

      Controversies in the literature on the pathophysiological hypotheses can be summed up as
      follows :

      FD is it an infectious folliculitis where SA (almost always found on the lesions plays a
      direct role possibly aided by a lack of local immune protection , or is it a pustular
      inflammatory unknown cause where the SA has no direct role but is a cofactor or a simple germ
      superinfection.

      Our study has plans to bring new evidence to help decide between these two opposite but not
      mutually exclusive concepts .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>presence of Staphylococcus Aureus in cutaneous biopsies (at least one colony)</measure>
    <time_frame>1 day</time_frame>
    <description>The primary endpoint is the presence of Staphylococcus Aureus in cutaneous biopsies before any therapy and notably antibiotics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>presence of Staphylococcus Aureus in cutaneous biopsies (at least one colony) after treatment</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence of Staphylococcus Aureus in nasal swab (at least one colony)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Folliculitis Decalvans</condition>
  <condition>Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>case</arm_group_label>
    <description>Patient with a folliculitis Decalvans</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>Control without folliculitis decalvans</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention : case control study</intervention_name>
    <arm_group_label>case</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with Folliculitis Decalvans
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt;18 yo)

          -  Alopecia

          -  folliculitis decalvans

          -  At least 6 months of evolution

          -  no antibiotics

          -  presence of pustules and crusts

          -  Adult (&gt;18 yo)

        Exclusion Criteria:

          -  immunosuppression

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saint-Louis Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2014</study_first_submitted>
  <study_first_submitted_qc>June 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2014</study_first_posted>
  <last_update_submitted>June 23, 2016</last_update_submitted>
  <last_update_submitted_qc>June 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>folliculitis decalvans</keyword>
  <keyword>Staphylococcus Aureus</keyword>
  <keyword>antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folliculitis</mesh_term>
    <mesh_term>Alopecia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

